Literature DB >> 1703054

IgM anti-idiotypes that block anti-HLA antibodies: naturally occurring or immune antibodies?

A Urlacher1, M M Tongio, J L Pasquali.   

Abstract

Using dithiothreitol (DTT) technique, IgM anti-HLA anti-idiotypic antibodies were detected in a multiparous multitransfused woman. These antibodies were able to inhibit the binding of specific IgG anti-HLA antibodies on their corresponding antigen. The recognized determinants were cross-reactive determinants since they were partially found on anti-HLA antibodies from unrelated individuals. By studying the patient's sera over a period of 2 years, no IgM-IgG switch was observed but the presence of these antibodies was stable in time, despite the disappearance of the idiotypes (anti-HLA antibodies). However, when looking at the patient's earlier serum, it was shown that these IgM anti-idiotypic antibodies were absent from the first available serum. Thus, these anti-idiotypic antibodies seem to behave both like natural and immune antibodies. The incidence of such antibodies in pretransplant patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703054      PMCID: PMC1535450          DOI: 10.1111/j.1365-2249.1991.tb05599.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Anti-idiotypic antibodies to HLA and their influence on patient sensitization.

Authors:  E Reed; M Hardy; J Brensilver; C Lattes; R McCabe; V D'gati; K Reemtsma; N Suciu-Foca
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

3.  Anti-idiotypic autoantibodies after donor-specific blood transfusions.

Authors:  H Toma; Y Hayasaka; M Yasuo; K Takahashi; S Teraoka; K Ota
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

4.  Idiotypic determinants of natural IgM antibodies that resemble self Ia antigens.

Authors:  D Holmberg; S Forsgren; L Forni; F Ivars; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Anti-idiotypic antibodies in a patient with a functioning renal graft.

Authors:  T Miyajima; R Higuchi; H Kashiwabara; T Yokoyama; S Fujimoto
Journal:  Nature       Date:  1980-01-17       Impact factor: 49.962

Review 6.  Genetics, expression, and function of idiotypes.

Authors:  K Rajewsky; T Takemori
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

7.  "Anti-idiotypic" antibodies to HLA in transiently sensitized DST patients.

Authors:  E Pohanka; R C Manfro; C Oto; B W Colombe; J S Melzer; N Feduska; O Salvatierra; M R Garovoy
Journal:  Hum Immunol       Date:  1989-09       Impact factor: 2.850

8.  Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.

Authors:  W J Burlingham; M H Pan; B Mason; S Ceman; H W Sollinger
Journal:  Transplantation       Date:  1988-06       Impact factor: 4.939

9.  Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype.

Authors:  B Barger; T W Shroyer; S L Hudson; M H Deierhoi; W H Barber; J J Curtis; B A Julian; R G Luke; A G Diethelm
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

10.  Induction of antiidiotypic antibodies by donor-specific blood transfusions. Establishment of a human-mouse hybridoma secreting the MLR-inhibiting factor.

Authors:  T Kawamura; K Sakagami; M Haisa; F Morisaki; S Takasu; M Inagaki; T Oiwa; K Orita
Journal:  Transplantation       Date:  1989-09       Impact factor: 4.939

View more
  2 in total

Review 1.  Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection.

Authors:  Yoshiko Matsuda; Takahisa Hiramitsu; Xiao-Kang Li; Takeshi Watanabe
Journal:  Pathogens       Date:  2020-12-23

2.  Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope.

Authors:  T C Rodman; F H Pruslin; S E To; R Winston
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.